Pfizer COVID-19 vaccine single dose reduces transmission, finds UK Study
London: A single dose of Pfizer-BioNtech's vaccine cuts the number of asymptomatic infections and could significantly reduce the risk of transmission of the virus, results of a UK study found on Friday.
Researchers analysed results from thousands of Covid-19 tests carried out each week as part of hospital screenings of health staff in Cambridge, England.
"Our findings show a dramatic reduction in the rate of positive screening tests among asymptomatic health workers after a single dose of the Pfizer-BioNTech vaccine," said Nick Jones, an infectious diseases specialist at Cambridge University Hospital, who co-led the study.
After separating the tests from unvaccinated and vaccinated staff, Jones' team found that 0.80% tests from unvaccinated health workers were positive. This compared with 0.37% of tests from staff less than 12 days post- vaccination — when the vaccine's protective effect is not yet fully established — and 0.20% of tests from staff at 12 days or more post-vaccination. The study is yet to be peer-reviewed. This suggests a four-fold decrease in the risk of asymptomatic infection amongst health workers who have been vaccinated for over 12 days, and 75% protection, said Mike Weekes of Cambridge University who also co-led the study.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.